Furthermore, patients with germline RB1 pathogenic variants are not only at higher risk of bilateral ocular disease but also at an increased risk of additional malignant neoplasms throughout their lives that are associated with significant morbidity and mortality (20, 21). This evidence concerns the gene RB1 and cancer.